Implementing Lutetium-PSMA — From Trial Design to Operations - Oliver Sartor
Oliver Sartor
Zachary Klaassen hosts Oliver Sartor to discuss the real-world implementation of lutetium PSMA-617 following PSMAfore trial approval in the pre-chemotherapy metastatic castration-resistant prostate cancer setting.